Biotechnology company BrainStorm Cell Therapeutics has announced plans to collaborate with two American institutions to test its experimental stem cell technology in people with amyotrophic lateral sclerosis (ALS) in the United States. The institutions are Massachusetts General Hospital in Boston and the University of Massachusetts Medical School in Worcester, Mass.
A one-year, MDA-supported study comparing a weekend-only prednisone treatment schedule with a daily prednisone schedule in boys with Duchenne muscular dystrophy (DMD) has found that the two treatment regimens provide about the same benefits and have approximately the same side-effect profile.
Do you know an exceptional kid between the age of 6 and 17 who has volunteered for MDA or supported someone with a neuromuscular disease? Here’s your chance to nominate him or her for some well-deserved recognition.
WWE (World Wrestling Entertainment) and MDA are looking for two Community Champions this summer: young people who have demonstrated “exceptional commitment” to supporting MDA or who have made a “significant contribution” to an individual with muscle disease within the last two years.
Belen Pappa, a graduate student in genetic counseling, is seeking participants for a survey-based study about psychosocial functioning in families in which a child has Duchenne muscular dystrophy (DMD).